| Sources | Names Used |
|---|---|
| CTRPv2 | 16-beta-bromoandrosterone |
| PharmacoGx | 16-beta-bromoandrosterone |
| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | C4orf46 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | ZXDC | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | RPRM | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | WWTR1 | CTRPv2 | pan-cancer | AAC | -0.14 | 0.002 |
| mRNA | RRH | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | SDSL | CTRPv2 | pan-cancer | AAC | -0.12 | 0.002 |
| mRNA | SPTY2D1 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | HMGB3 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | RP11-214K3.25 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | BICDL2 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
